Cambiar Aggressive Value ETF CAMX
36.69 USD +1.43 (+4.06%)
At closeNov 4, 2026, 4:10 PM EST
36.69 0.00 0.00%
After hours · Nov 4, 4:10 PM ET
36.26 Day range 36.69
29.89 52-week range 36.69
- YTD
- +16.43%
- 1 year
- +18.23%
- Market cap
- 67.70M
- EPS (ttm)
- 1.98
- P/E ratio
- 18.56
- YTD return
- +16.43%
- 1-year return
- +18.23%
- Volume
- 1.11K
- Avg volume
- 248
- Open
- 36.26
- Previous close
- 35.25
- Day's range
- 36.26 – 36.69
- 52-week range
- 29.89 – 36.69
2Y +5.59 (+18.84%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 30.21
- 200-day average
- 29.27
About Cambiar Aggressive Value ETF
Under normal circumstances, the fund primarily invests in equity securities of companies located in the United States. The fund typically invests in a portfolio of 20-30 issuers that Cambiar Investors, the fund’s investment adviser, believes represent the best opportunities for long-term capital appreciation. The fund is non-diversified.
News
What Is Going On With Uber Stock on Tuesday? 
From Burritos to Bulk Groceries: Uber Scales Delivery Reach with ShopRite Partner 
Uber Axes 3,300 Jobs to Build Its Autonomous Future 
Albany Engineered Composites to Showcase Advanced Composite Solutions at CAMX 2026 
Honeywell Dumps Productivity Unit In $1.4 Billion Deal With Brady 
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly 
Why Elevance Health Shares Are Surging Premarket On Wednesday? 
Delta Earnings Showcase 2025 Worries & Active ETF Opportunities 
CME Group Expands Nikkei Futures Offerings, Boosts Japanese Equity Derivatives 
Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients
Your note
Sign in to keep a note on CAMX — it syncs with the Stock Master app.